Cargando…

Different Non-selective β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease

Detalles Bibliográficos
Autores principales:	Wang, Cheng-Yi, Wang, Ya-Hui, Lai, Chih-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543192/ https://www.ncbi.nlm.nih.gov/pubmed/31193870 http://dx.doi.org/10.1016/j.eclinm.2019.04.013

Ejemplares similares

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Increase use of β-blockers in patients with chronic obstructive pulmonary and cardiovascular disease
por: Yang, Yan-Li, et al.
Publicado: (2021)

β1-blocker in sepsis
por: Hasegawa, Daisuke, et al.
Publicado: (2021)

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
por: Huang, Yueh Lan, et al.
Publicado: (2017)

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

Chronic obstructive pulmonary disease and β‐blocker treatment in Asian patients with heart failure
por: Kubota, Yoshiaki, et al.
Publicado: (2017)

Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease
por: Verdecchia, Paolo, et al.
Publicado: (2021)

β-blockers in septic shock: are we there yet?
por: Cruz, Madalena Coutinho, et al.
Publicado: (2017)

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2015)

Chronic obstructive pulmonary disease and tuberculosis
por: Jain, Nirmal Kumar
Publicado: (2017)

Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
por: Short, Philip M, et al.
Publicado: (2011)

The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials
por: Lai, Chih-Cheng, et al.
Publicado: (2019)

Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study
por: Dong, Yaa-Hui, et al.
Publicado: (2017)

Gene-environment interactions in chronic obstructive pulmonary disease
por: Molfino, Nestor A, et al.
Publicado: (2008)

The dendritic cell niche in chronic obstructive pulmonary disease
por: Haczku, Angela
Publicado: (2012)

A Patient Charter for Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2020)

The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications
por: Yeh, Wen-Shuo, et al.
Publicado: (2019)

Premorbid β1-selective (but not non-selective) β-blocker exposure reduces intensive care unit mortality among septic patients
por: Kuo, Ming-Jen, et al.
Publicado: (2021)

Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies
por: Hong, Shiao-Ya, et al.
Publicado: (2023)

Palliative care provision for patients with chronic obstructive pulmonary disease
por: Yohannes, Abebaw Mengistu
Publicado: (2007)

Chronic obstructive pulmonary disease: More than meets the eye
por: Hatipoğlu, Umur
Publicado: (2018)

A new cytokine target for chronic obstructive pulmonary disease?
por: Bernhagen, Jürgen
Publicado: (2021)

Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease
por: Zvizdic, Faris, et al.
Publicado: (2019)

Effect of Perioperative β-Blockers on Pulmonary Complications among Patients with Chronic Obstructive Pulmonary Disease Undergoing Lung Resection Surgery
por: Kamath, A., et al.
Publicado: (2015)

Avoidance of β-blockers in patients who use stimulants is not supported by good evidence
por: Wilson, Tyler, et al.
Publicado: (2022)

Angiotensin Receptor Blocker Associated with a Decreased Risk of Lung Cancer: An Updated Meta-Analysis
por: Wang, Zexu, et al.
Publicado: (2023)

Conventional, Complementary and Alternative Medicines: Mechanistic Insights into Therapeutic Landscape of Chronic Obstructive Pulmonary Disease
por: Arezina, Radivoj, et al.
Publicado: (2023)

β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals
por: Nielsen, Anne Orholm, et al.
Publicado: (2019)

Another step for noninvasive ventilation in chronic obstructive pulmonary disease patients!
por: Jaber, Samir, et al.
Publicado: (2010)

Emerging role of pharmacists in managing patients with chronic obstructive pulmonary disease
por: Hudd, Timothy R
Publicado: (2020)

The Importance of the Diaphragm in Neuromotor Function in the Patient with Chronic Obstructive Pulmonary Disease
por: Bordoni, Bruno, et al.
Publicado: (2023)

Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis
por: Yang, Yan-Li, et al.
Publicado: (2020)

Neurally adjusted non-invasive ventilation in patients with chronic obstructive pulmonary disease: does patient–ventilator synchrony matter?
por: Nava, Stefano, et al.
Publicado: (2014)

Coexistent obstructive sleep apnea in patients with chronic obstructive pulmonary disease: Several unanswered questions need to be addressed
por: Voulgaris, Athanasios, et al.
Publicado: (2021)

Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers
por: Chapman, Kenneth R., et al.
Publicado: (2021)

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol
por: Bhatt, Surya P, et al.
Publicado: (2016)

Impaired function of upper limb muscles in patients with chronic obstructive pulmonary disease
por: Rassler, Beate
Publicado: (2013)

Macrophage function in chronic obstructive pulmonary disease: The many faces of notch signalling
por: Hiemstra, Pieter S.
Publicado: (2019)

Acute exacerbation of chronic obstructive pulmonary disease: The clot matters a lot!
por: Padmanabhan, Arjun, et al.
Publicado: (2021)

β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study
por: Su, Tse-Hsuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4emk0m4k217f22vcokpe5h4g0s